Understand the source comparison
SS-LUP-332 with Alcohol Safety: Compound Comparison
SS-LUP-332 ERRα agonist. Mitochondrial biogenesis via PGC-1α upregulation High. Ethanol suppresses ERRα transcriptional activity by 35–42% within 12 hours 48 hours minimum between alcohol exposure and peptide dose Strict separation mandatory. Pathway overlap m
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- SS-LUP-332
- ERRα agonist. Mitochondrial biogenesis via PGC-1α upregulation
- High. Ethanol suppresses ERRα transcriptional activity by 35–42% within 12 hours
- 48 hours minimum between alcohol exposure and peptide dose
- Strict separation mandatory. Pathway overlap makes concurrent use scientifically invalid for metabolic studies
- GW501516 (Cardarine)
- PPARδ agonist. Fatty acid oxidation and endurance
- Moderate. Alcohol shifts substrate utilization but does not directly antagonize PPARδ
- 24–36 hours recommended for controlled studies
- Less mechanistic conflict than SS-LUP-332, but alcohol still confounds lipid metabolism endpoints
- AICAR
- AMPK activator. Glucose uptake and mitochondrial function
- Moderate. Ethanol impairs AMPK signaling indirectly via NAD+ depletion
- 24 hours minimum for metabolic clarity
- Compatible with occasional alcohol exposure in non-metabolic studies, problematic for glucose/insulin research
- Metformin
- AMPK activator. Hepatic glucose suppression
- Low. Mechanism operates independently of acute ethanol effects
- No specific washout required for research protocols
- Alcohol interaction concerns are pharmacokinetic (lactic acidosis risk in clinical use), not mechanistic for research
- The comparison underscores a critical point: not all mitochondrial compounds interact with alcohol the same way. SS-LUP-332's dependence on ERRα. A receptor ethanol directly suppresses. Makes it uniquely sensitive to alcohol interference. Researchers switching from other metabolic modulators cannot assume the same protocol flexibility.